Literature DB >> 7166183

Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: II. Tissue distribution.

G Campistron, R Guiraud, J Cros, G Prat.   

Abstract

The distribution of arginine and aspartic acid in brain, testes and liver was studied in rats after the simultaneous oral and intravenous administration of 0.1 mmol of these two amino acids. Exogenous fractions were determined by incorporation of [U-14C]-arginine and [3H]-aspartic acid. A significant increase in the free forms of the two amino acids was observed in all the organs except the liver where aspartic acid decreased after intravenous administration. The oral route induced higher concentrations of arginine in the testes and the brain and of aspartic acid in the liver. The concentrations of aspartic acid were higher in the brain and the testes after intravenous administration. Up to 15% of the dose of arginine administered was found in the liver, most of it bound to protein. Free aspartic acid concentrations underwent two successive increases with return to baseline values between the two phases. The first phase seemed to be due to an accumulation of the amino acid in the organ, followed by binding of the amino acid to the proteins. The second increase seemed to be due to a displacement of the protein bound form towards the free form. The steep rise in cerebral arginine levels, peaking at 30 minutes, may be one of the determining factors governing GH secretion induced by the simultaneous oral administration of aspartic acid and arginine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7166183     DOI: 10.1007/BF03189635

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  16 in total

1.  The excitation and depression of spinal neurones by structurally related amino acids.

Authors:  D R CURTIS; J C WATKINS
Journal:  J Neurochem       Date:  1960-09       Impact factor: 5.372

2.  [Localization of arginine aspartate in the organism after repeated doses].

Authors:  P Blanquet; J Laparra
Journal:  Sem Ther       Date:  1968-12

3.  The uptake of various amino acids by the mouse brain in vivo.

Authors:  L Battistin; A Grynbaum; A Lajtha
Journal:  Brain Res       Date:  1971-06-04       Impact factor: 3.252

4.  Regional distribution of endogenous and parenteral glutamate, aspartate and glutamine in rat brain.

Authors:  J Liebschutz; L Airoldi; M J Brownstein; N G Chinn; R J Wurtman
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

5.  The effect of cochlear nerve lesion on the release of glutamate, aspartate, and GABA from cat cochlear nucleus, in vitro.

Authors:  V Canzek; J C Reubi
Journal:  Exp Brain Res       Date:  1980       Impact factor: 1.972

6.  Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: I. Plasma kinetics.

Authors:  G Campistron; R Guiraud; J Cros; J Mosser
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

Review 7.  Absorption, utilization, and safety of aspartic acid.

Authors:  L D Stegink
Journal:  J Toxicol Environ Health       Date:  1976-09

8.  Antagonizing effect of aspartic acid on the development of physical dependence on and tolerance to morphine in the rat.

Authors:  H Koyuncuoglu; H Sagduyu; M Güngör; L Eroglu; E Genç
Journal:  Arzneimittelforschung       Date:  1977

9.  [Changes in the reactive properties of the body under anesthesia against a background of aspartic acid premedication].

Authors:  G E Batrak; A K Iarosh
Journal:  Farmakol Toksikol       Date:  1980 May-Jun

10.  Aspartate and glutamate as possible neurotransmitters of cells in layer 6 of the visual cortex.

Authors:  R W Baughman; C D Gilbert
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

View more
  2 in total

1.  Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat--III: Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid.

Authors:  G Campistron; R Guiraud; J Cros; H Pontagnier
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

2.  Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.

Authors:  Yuri C Martins; Graziela M Zanini; John A Frangos; Leonardo J M Carvalho
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.